Notably, weight loss appeared to be exposure-dependent, with the cohort receiving the maximum dose of 2 mg/day for the entire study exhibiting the greatest weight loss ( Table 2 )
FDA and Manufacturer Guidance The FDA and drug manufacturers generally do not recommend using GLP-1 medications while breastfeeding due to limited human safety data, not because harm has been demonstrated
However, GLP1-RA may have iatrogenic effects with respect to Atypical Anorexia, Bulimia Nervosa, and ARFID
Compounding is a legitimate, regulated pharmaceutical practice with a long history
2): The formation of peroxyl radicals leads to the production of organic hydroperoxides, which, in turn, can abstract hydrogen from another PUFA, analogous to reaction 1: This reaction is termed propagation, implying that one initiating hit results in the conversion of numerous PUFA to lipid hydroperoxides
Adems La prdida de peso repercute en estos pacientes en un beneficio en parmetros cardiometablicos clave, como el descenso de los triglicridos (24,3 - 31,4 %), de la tensin arterial (tanto sistlica como diastlica) y un impacto positivo en los niveles de colesterol (con mejoras en el HDL y reducciones en LDL)
